{"id":"https://openalex.org/W4361875813","doi":"https://doi.org/10.1158/0008-5472.22414427","title":"Supplementary Tables 1-3 and Figures 1-9 from Phosphoproteomic Profiling Reveals ALK and MET as Novel Actionable Targets across Synovial Sarcoma Subtypes","display_name":"Supplementary Tables 1-3 and Figures 1-9 from Phosphoproteomic Profiling Reveals ALK and MET as Novel Actionable Targets across Synovial Sarcoma Subtypes","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361875813","doi":"https://doi.org/10.1158/0008-5472.22414427"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.22414427","doi":"https://doi.org/10.1158/0008-5472.22414427","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22414427","pdf_url":"https://aacr.figshare.com/ndownloader/files/39860459","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/ndownloader/files/39860459","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004235393","display_name":"Emmy D.G. Fleuren","orcid":"https://orcid.org/0000-0001-6202-6861","observed_orcids":["https://orcid.org/0000-0001-6202-6861"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emmy D.G. Fleuren","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012955112","display_name":"Myrella Vlenterie","orcid":"https://orcid.org/0000-0002-4523-4084","observed_orcids":["https://orcid.org/0000-0002-4523-4084"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Myrella Vlenterie","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055163903","display_name":"Winette T.A. van der Graaf","orcid":"https://orcid.org/0000-0001-7549-3338","observed_orcids":["https://orcid.org/0000-0001-7549-3338"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Winette T.A. van der Graaf","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024830756","display_name":"Melissa H.S. Hillebrandt-Roeffen","orcid":"https://orcid.org/0009-0001-9887-8959","observed_orcids":["https://orcid.org/0009-0001-9887-8959"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melissa H.S. Hillebrandt-Roeffen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"James Blackburn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James Blackburn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111648222","display_name":"Xiuquan Ma","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiuquan Ma","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113171253","display_name":"Howard Chan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Howard Chan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060381690","display_name":"Mandy C. Magias","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mandy C. Magias","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056218109","display_name":"Anke E. M. van Erp","orcid":"https://orcid.org/0000-0002-8694-922X","observed_orcids":["https://orcid.org/0000-0002-8694-922X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anke van Erp","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084038820","display_name":"Laurens van Houdt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laurens van Houdt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043990913","display_name":"Sabri A.S. Cebeci","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sabri A.S. Cebeci","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018198549","display_name":"Amy van de Ven","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amy van de Ven","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004194069","display_name":"Uta E. Flucke","orcid":"https://orcid.org/0000-0003-0315-4307","observed_orcids":["https://orcid.org/0000-0003-0315-4307"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Uta E. Flucke","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082915656","display_name":"Erin E. Heyer","orcid":"https://orcid.org/0000-0003-3426-9350","observed_orcids":["https://orcid.org/0000-0003-3426-9350"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erin E. Heyer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057483557","display_name":"David Morgan Thomas","orcid":"https://orcid.org/0000-0002-2527-5428","observed_orcids":["https://orcid.org/0000-0002-2527-5428"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David M. Thomas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088018441","display_name":"Christopher J. Lord","orcid":"https://orcid.org/0000-0002-3226-0515","observed_orcids":["https://orcid.org/0000-0002-3226-0515"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher J. Lord","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061906839","display_name":"Kieren D. Marini","orcid":"https://orcid.org/0000-0001-8399-4757","observed_orcids":["https://orcid.org/0000-0001-8399-4757"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kieren D. Marini","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006102759","display_name":"Vijesh Vaghjiani","orcid":"https://orcid.org/0000-0001-8004-3876","observed_orcids":["https://orcid.org/0000-0001-8004-3876"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vijesh Vaghjiani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089375087","display_name":"Tim R. Mercer","orcid":"https://orcid.org/0000-0001-8780-894X","observed_orcids":["https://orcid.org/0000-0001-8780-894X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tim R. Mercer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066009774","display_name":"Jason E. Cain","orcid":"https://orcid.org/0000-0003-3987-5894","observed_orcids":["https://orcid.org/0000-0003-3987-5894"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jason E. Cain","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108140465","display_name":"Jianmin Wu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jianmin Wu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018890674","display_name":"Yvonne M.H. Versleijen\u2010Jonkers","orcid":"https://orcid.org/0000-0001-7623-0505","observed_orcids":["https://orcid.org/0000-0001-7623-0505"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yvonne M.H. Versleijen-Jonkers","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5060521527","display_name":"Roger J. Daly","orcid":"https://orcid.org/0000-0002-5739-8027","observed_orcids":["https://orcid.org/0000-0002-5739-8027"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roger J. Daly","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/synovial-sarcoma","display_name":"synovial sarcoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/anaplastic-lymphoma-kinase","display_name":"anaplastic lymphoma kinase","score":0.7749999761581421},{"id":"https://openalex.org/keywords/met","display_name":"MET","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pdgfra","display_name":"PDGFRA","score":0.9459999799728394},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.8610000014305115},{"id":"https://openalex.org/keywords/actionable-therapeutic-targets","display_name":"actionable targets","score":0.5849999785423279},{"id":"https://openalex.org/keywords/phosphoproteomics","display_name":"phosphoproteomics","score":0.878000020980835},{"id":"https://openalex.org/keywords/protein-protein-interaction-network","display_name":"protein-protein interaction network","score":0.8339999914169312},{"id":"https://openalex.org/keywords/cell-cycle","display_name":"cell cycle","score":0.5299999713897705},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":1.0},{"id":"https://openalex.org/keywords/foretinib","display_name":"foretinib","score":0.7590000033378601},{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.9909999966621399},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":0.996999979019165},{"id":"https://openalex.org/keywords/deglycosylation","display_name":"deglycosylation","score":0.7250000238418579},{"id":"https://openalex.org/keywords/soft-tissue-sarcoma","display_name":"soft tissue sarcoma","score":0.7149999737739563},{"id":"https://openalex.org/keywords/sarcoma-subtypes","display_name":"sarcoma subtypes","score":0.5960000157356262}],"concepts":[{"id":"https://openalex.org/C37307934","wikidata":"https://www.wikidata.org/wiki/Q18030422","display_name":"PDGFRA","level":4,"score":0.5869497060775757},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5544765591621399},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.5279209613800049},{"id":"https://openalex.org/C2776910622","wikidata":"https://www.wikidata.org/wiki/Q2619315","display_name":"Synovial sarcoma","level":3,"score":0.49127620458602905},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4656641483306885},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.3582756519317627},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23860666155815125},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.23109784722328186},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.1681700050830841},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.1620180606842041},{"id":"https://openalex.org/C2775922572","wikidata":"https://www.wikidata.org/wiki/Q83567","display_name":"GiST","level":3,"score":0.12124201655387878},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.10692629218101501}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.22414427","doi":"https://doi.org/10.1158/0008-5472.22414427","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22414427","pdf_url":"https://aacr.figshare.com/ndownloader/files/39860459","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.22414427","doi":"https://doi.org/10.1158/0008-5472.22414427","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22414427","pdf_url":"https://aacr.figshare.com/ndownloader/files/39860459","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.5400000214576721,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361875813.pdf","grobid_xml":"https://content.openalex.org/works/W4361875813.grobid-xml"},"referenced_works_count":10,"referenced_works":["https://openalex.org/W1571073982","https://openalex.org/W2020585594","https://openalex.org/W2033167804","https://openalex.org/W2036897871","https://openalex.org/W2038195711","https://openalex.org/W2059094534","https://openalex.org/W2076819367","https://openalex.org/W2079420659","https://openalex.org/W2102619694","https://openalex.org/W2169456326"],"related_works":["https://openalex.org/W2328276963","https://openalex.org/W2137853367","https://openalex.org/W2107587741","https://openalex.org/W2024296733","https://openalex.org/W3180620047","https://openalex.org/W3134550072","https://openalex.org/W158419439","https://openalex.org/W3007070331","https://openalex.org/W2189518071","https://openalex.org/W2025410805"],"abstract_inverted_index":{"This":[0],"file":[1,195],"contains":[2],"the":[3],"following":[4],"supplemental":[5],"data:":[6],"Supplemental":[7,20,29,41,55,66,79,92,101,113,129,141,157,169],"Table":[8,21,30,42],"1.":[9,57],"Specific":[10],"information":[11],"for":[12,36,62],"MTT":[13],"cell":[14,47,77,105,121],"viability":[15],"assays":[16],"with":[17],"single":[18],"agents.":[19],"2.":[22,68],"Patient":[23],"characteristics":[24,164],"of":[25,33,45,84,96,117,133,165,173,185],"synovial":[26],"sarcoma":[27,64],"cohort.":[28],"3.":[31,81],"Specifications":[32],"antibodies":[34],"used":[35],"IHC":[37,161],"and":[38,71,75,111,123,146,162,175,188],"Western":[39],"Blot.":[40],"6.":[43,115],"Summary":[44],"SS":[46,104,152,167],"line":[48,106],"sensitivity":[49,107],"to":[50,108],"specific":[51],"tyrosine":[52],"kinase":[53],"inhibitors.":[54],"Figure":[56,67,80,93,102,114,130,142,158,170],"Integrated":[58],"protein-protein":[59],"interaction":[60],"network":[61],"all":[63],"subgroups.":[65],"ALK":[69,85,97,118,134,160],"expression":[70,149],"phosphorylation":[72],"in":[73,89,98,126,138,150,180,193],"ES":[74],"RMS":[76],"lines.":[78],"Schematic":[82],"representation":[83],"exon":[86],"2-17":[87],"deletion":[88],"Aska-SS":[90,99,127,137],"cells.":[91,100,128,182],"4.":[94],"Deglycosylation":[95],"5.":[103],"foretinib,":[109],"gefitinib":[110],"erlotinib.":[112],"Effects":[116,132],"inhibition":[119,135,177],"on":[120,136,178],"cycle":[122],"apoptotic":[124],"markers":[125],"7.":[131],"vivo":[139],"tumors.":[140,168],"8.":[143],"ALK,":[144],"MET":[145,176],"PDGFRA":[147],"mRNA":[148],"clinical":[151],"versus":[153],"other":[154],"STS":[155],"samples.":[156],"9.":[159],"patient":[163],"ALK-positive":[166],"10.":[171],"Effect":[172],"PDGFR":[174],"apoptosis":[179],"Yamato-SS":[181],"Brief":[183],"sections":[184],"Supplementary":[186,189],"methods":[187],"references":[190],"are":[191],"included":[192],"this":[194],"as":[196],"well.":[197]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2025-10-10T00:00:00"}